admin • 22 April 2026
Navigating Market Entry in Advanced Therapies: A Strategic
Large pharma companies are increasingly pursuing strategic divestitures to sharpen focus on core therapeutic areas
Read more
Latest insights
Stay informed with our latest perspectives on life science growth, M&A trends, and market opportunities.
Feature
admin • 22 April 2026
The Rise of Compounding Pharmacies
Large pharma companies are increasingly pursuing strategic divestitures to sharpen focus on core therapeutic areas
Read more
Trending posts
Discover how innovation and creativity drive meaningful change
admin • 22 April 2026
admin • 22 April 2026
Navigating Market Entry in Advanced Therapies: A Strategic
Large pharma companies are increasingly pursuing strategic divestitures to sharpen focus on core therapeutic areas
Read more
admin • 22 April 2026
The evolving CDMO landscape: opportunities in biologics manufacturing
As demand for biologics continues to surge, the CDMO sector presents significant opportunities for strategic…
Read more
admin • 9 April 2026
The Rise of Compounding Pharmacies
Large pharma companies are increasingly pursuing strategic divestitures to sharpen focus on core therapeutic areas
Read more
admin • 9 April 2026
Navigating Market Entry in Advanced Therapies: A Strategic
Large pharma companies are increasingly pursuing strategic divestitures to sharpen focus on core therapeutic areas
Read more
admin • 9 April 2026
Digital Health Integration: Bridging Innovation and Traditional Pharma
Large pharma companies are increasingly pursuing strategic divestitures to sharpen focus on core therapeutic areas
Read more
Frequently asked questions
A comprehensive guide to common queries, offering deeper insights into how we support your growth journey from strategy to execution.
What types of companies does Tulevik work with?
We work with life science innovators, operators, service providers, and investors across the pharmaceutical, biotech, advanced therapies, pharma services, digital health, and MedTech sectors.
What types of companies does Tulevik work with?
How does Tulevik's analytic platform differ from traditional advisory approaches?
What engagement models does Tulevik offer?
What geographies does Tulevik cover?